Read the Journal of Managed Care + Specialty Pharmacy (JMCP) March 2025 Issue
JMCP Findings - Bridging the Gaps in Precision Oncology: Opportunities in Non-Small Cell Lung Cancer
FINDINGS FROM THE AMCP MARKET INSIGHTS PROGRAM | July, 2023
Summary
Lung cancer is the most common cancer worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all lung cancers. The National Institutes of Health estimated that cancer care cost the US $208.9 billion in 2020, $23.8 billion of which was due to lung cancer. View the full fundings from the program on JMCP.
For more disease state research, view the Market Insights Program.
Related
View our Market Insights webinar that features an enlightening exploration of the intersection between mental health and rare diseases.
Stay ahead of industry shifts with insights from the AMCP Foundation’s Emerging Trends Initiative. Published in JMCP, this report explores key developments in technology, therapeutics, payment models, pharmacy operations, and policy. Learn how these trends impact managed care pharmacy professionals and what they mean for you and your business.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
